Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001564590-17-006750
Filing Date
2017-04-20
Accepted
2017-04-20 08:00:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 8-K mstx-8k_20170420.htm 425 41415
2 EX-99.1 mstx-ex991_6.htm EX-99.1 23841
3 GRAPHIC g201704200104307556226.jpg GRAPHIC 4304
  Complete submission text file 0001564590-17-006750.txt   73361
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filed by) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-32157 | Film No.: 17771462
SIC: 2834 Pharmaceutical Preparations